Company Filing History:
Years Active: 2012-2013
Title: Carsten Hopf: Innovator in JAK Kinase Research
Introduction
Carsten Hopf is a notable inventor based in Mannheim, Germany. He has made significant contributions to the field of biochemistry, particularly in the study of JAK kinases and LRRK2 inhibitors. With a total of 2 patents, his work has implications for therapeutic developments in various diseases.
Latest Patents
Carsten Hopf's latest patents include innovative methods for the identification of JAK kinase interacting molecules and for the purification of JAK kinases. These inventions relate to immobilization compounds and methods that are useful for identifying JAK interacting compounds or for the purification of JAK. Additionally, he has developed methods for the identification of leucine-rich kinase 2 (LRRK2) interacting molecules. This invention features methods for identifying LRRK2 inhibitors using indol ligand 91, which includes identifying compounds that compete with indol ligand 91 for binding to LRRK2.
Career Highlights
Throughout his career, Carsten Hopf has worked with prominent companies in the biotechnology sector, including Cellzome AG and Cellzome Limited. His expertise in kinase research has positioned him as a valuable contributor to advancements in this field.
Collaborations
Carsten has collaborated with various professionals, including Gerard Drewes, to further his research and innovations.
Conclusion
Carsten Hopf's contributions to the field of biochemistry, particularly through his patents and collaborations, highlight his role as an influential inventor. His work continues to pave the way for advancements in therapeutic applications related to JAK kinases and LRRK2.